Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients

Abstract Background Diabetes is a serious and quickly expanding global health problem. Cardiovascular disease is the leading cause of mortality in type 2 diabetes mellitus (T2DM) patients. Coronary slow flow (CSF) is characterised by delayed distal perfusion during coronary angiography with normal c...

Full description

Bibliographic Details
Main Authors: Moataz Ali Hasan Ali Elsanan, Islam Hussein Hassan Hussein Tahoon, Ghada Ibrahim Mohamed, Shimaa Gamal ZeinElabdeen, Islam Elsayed Shehata
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-023-03275-y
_version_ 1827948239090876416
author Moataz Ali Hasan Ali Elsanan
Islam Hussein Hassan Hussein Tahoon
Ghada Ibrahim Mohamed
Shimaa Gamal ZeinElabdeen
Islam Elsayed Shehata
author_facet Moataz Ali Hasan Ali Elsanan
Islam Hussein Hassan Hussein Tahoon
Ghada Ibrahim Mohamed
Shimaa Gamal ZeinElabdeen
Islam Elsayed Shehata
author_sort Moataz Ali Hasan Ali Elsanan
collection DOAJ
description Abstract Background Diabetes is a serious and quickly expanding global health problem. Cardiovascular disease is the leading cause of mortality in type 2 diabetes mellitus (T2DM) patients. Coronary slow flow (CSF) is characterised by delayed distal perfusion during coronary angiography with normal coronary arteries. This study aimed to investigate the correlation between CSF and inflammatory markers regarding glycemic status in T2DM. Methods This cross-sectional study included 120 patients who were divided equally into 4 groups according to their glycemic control and presence or absence of coronary slow flow: Group I included patients with T2DM with good glycemic control without CSF; Group II included patients with T2DM with good glycemic control and CSF; Group III included patients with T2DM with poor glycemic control without CSF; and Group IV included patients with T2DM with poor glycemic control and CSF. The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), platelets, hematocrit, and haemoglobin were also evaluated as risk factors for coronary slow flow. Results This study showed that body mass index (BMI), hematocrit level, NLR, and CRP demonstrated a moderate but significant correlation (r = 0.53) with CSF in poorly controlled T2DM. NLR cutoff > 2.1 could predict CSF in poorly controlled T2DM with a modest sensitivity and specificity. A 1.9 increase in HbA1c increases the likelihood of coronary slow flow. Dylipidemia increases the likelihood of coronary slow flow by 0.18 times. Other predictors for coronary slow flow include NLR, PLR, CRP, platelets, hematocrit, and hemoglobin. The effect of the predictors is still statistically significant after being adjusted for glycemic status, age, and sex (p  < 0.001). Conclusions Poor glycemic control increases the incidence of CSF. This supports the hypothesis that CSF is related to endothelial dysfunction as poor glycemic control causes endothelial dysfunction due to inflammation. Trial registration ZU-IRB#9419–3-4–2022 Registered 3 April 2022, email.  IRB_123@medicine.zu.edu.eg .
first_indexed 2024-04-09T12:52:16Z
format Article
id doaj.art-00a67715906e48a7a6309fedb9554156
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-04-09T12:52:16Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-00a67715906e48a7a6309fedb95541562023-05-14T11:07:40ZengBMCBMC Cardiovascular Disorders1471-22612023-05-012311810.1186/s12872-023-03275-yRelationship between inflammatory markers and coronary slow flow in type 2 diabetic patientsMoataz Ali Hasan Ali Elsanan0Islam Hussein Hassan Hussein Tahoon1Ghada Ibrahim Mohamed2Shimaa Gamal ZeinElabdeen3Islam Elsayed Shehata4Department of Cardiology, Faculty of Medicine, Zagazig UniversityDepartment of Cardiology, Faculty of Medicine, Zagazig UniversityDepartment of Cardiology, Faculty of Medicine, Zagazig UniversityDepartment of Cardiology, Faculty of Medicine, Zagazig UniversityDepartment of Cardiology, Faculty of Medicine, Zagazig UniversityAbstract Background Diabetes is a serious and quickly expanding global health problem. Cardiovascular disease is the leading cause of mortality in type 2 diabetes mellitus (T2DM) patients. Coronary slow flow (CSF) is characterised by delayed distal perfusion during coronary angiography with normal coronary arteries. This study aimed to investigate the correlation between CSF and inflammatory markers regarding glycemic status in T2DM. Methods This cross-sectional study included 120 patients who were divided equally into 4 groups according to their glycemic control and presence or absence of coronary slow flow: Group I included patients with T2DM with good glycemic control without CSF; Group II included patients with T2DM with good glycemic control and CSF; Group III included patients with T2DM with poor glycemic control without CSF; and Group IV included patients with T2DM with poor glycemic control and CSF. The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), platelets, hematocrit, and haemoglobin were also evaluated as risk factors for coronary slow flow. Results This study showed that body mass index (BMI), hematocrit level, NLR, and CRP demonstrated a moderate but significant correlation (r = 0.53) with CSF in poorly controlled T2DM. NLR cutoff > 2.1 could predict CSF in poorly controlled T2DM with a modest sensitivity and specificity. A 1.9 increase in HbA1c increases the likelihood of coronary slow flow. Dylipidemia increases the likelihood of coronary slow flow by 0.18 times. Other predictors for coronary slow flow include NLR, PLR, CRP, platelets, hematocrit, and hemoglobin. The effect of the predictors is still statistically significant after being adjusted for glycemic status, age, and sex (p  < 0.001). Conclusions Poor glycemic control increases the incidence of CSF. This supports the hypothesis that CSF is related to endothelial dysfunction as poor glycemic control causes endothelial dysfunction due to inflammation. Trial registration ZU-IRB#9419–3-4–2022 Registered 3 April 2022, email.  IRB_123@medicine.zu.edu.eg .https://doi.org/10.1186/s12872-023-03275-yDiabetes type 2Coronary slow flowInflammatory markers (NLR, PLR)
spellingShingle Moataz Ali Hasan Ali Elsanan
Islam Hussein Hassan Hussein Tahoon
Ghada Ibrahim Mohamed
Shimaa Gamal ZeinElabdeen
Islam Elsayed Shehata
Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients
BMC Cardiovascular Disorders
Diabetes type 2
Coronary slow flow
Inflammatory markers (NLR, PLR)
title Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients
title_full Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients
title_fullStr Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients
title_full_unstemmed Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients
title_short Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients
title_sort relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients
topic Diabetes type 2
Coronary slow flow
Inflammatory markers (NLR, PLR)
url https://doi.org/10.1186/s12872-023-03275-y
work_keys_str_mv AT moatazalihasanalielsanan relationshipbetweeninflammatorymarkersandcoronaryslowflowintype2diabeticpatients
AT islamhusseinhassanhusseintahoon relationshipbetweeninflammatorymarkersandcoronaryslowflowintype2diabeticpatients
AT ghadaibrahimmohamed relationshipbetweeninflammatorymarkersandcoronaryslowflowintype2diabeticpatients
AT shimaagamalzeinelabdeen relationshipbetweeninflammatorymarkersandcoronaryslowflowintype2diabeticpatients
AT islamelsayedshehata relationshipbetweeninflammatorymarkersandcoronaryslowflowintype2diabeticpatients